152 related articles for article (PubMed ID: 25861231)
21. Hypercalcemia and elevated serum 1.25-dihydroxyvitamin D in an end-stage renal disease patient with pulmonary cryptococcosis.
Wang IK; Shen TY; Lee KF; Chang HY; Lin CL; Chuang FR
Ren Fail; 2004 May; 26(3):333-8. PubMed ID: 15354986
[TBL] [Abstract][Full Text] [Related]
22. [Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma].
Renal Impairment of Multiple Myeloma Collaborative Study Group
Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):871-875. PubMed ID: 29136724
[TBL] [Abstract][Full Text] [Related]
23. Laboratory Features of Newly Diagnosed Multiple Myeloma Patients.
Hussain A; Almenfi HF; Almehdewi AM; Hamza MS; Bhat MS; Vijayashankar NP
Cureus; 2019 May; 11(5):e4716. PubMed ID: 31355076
[TBL] [Abstract][Full Text] [Related]
24. Clinical aspects of multiple myeloma and related disorders including amyloidosis.
Kyle RA
Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881
[TBL] [Abstract][Full Text] [Related]
25. Radiologic Findings in Polyarticular Amyloid Arthropathy and Myopathy in Multiple Myeloma: A Case Report.
Khoo HW; Ding CSL; Tandon AA
Am J Case Rep; 2018 Nov; 19():1398-1404. PubMed ID: 30470733
[TBL] [Abstract][Full Text] [Related]
26. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Zagouri F; Kastritis E; Zomas A; Terpos E; Katodritou E; Symeonidis A; Delimpasi S; Pouli A; Vassilakopoulos TP; Michalis E; Giannouli S; Kartasis Z; Christoforidou A; Kokoviadou K; Hatzimichael E; Gika D; Megalakaki C; Papaioannou M; Kyrtsonis MC; Konstantopoulos K; Dimopoulos MA;
Eur J Haematol; 2017 Nov; 99(5):409-414. PubMed ID: 28675766
[TBL] [Abstract][Full Text] [Related]
27. Hypercalcemia due to giant cell myocarditis: a case report.
Patel AM; Jessup M; Tomaszewski J; Doyle A
Prog Transplant; 2013 Dec; 23(4):365-7. PubMed ID: 24311400
[TBL] [Abstract][Full Text] [Related]
28. The Coexistence of Multiple Myeloma-associated Amyloid Light-chain Amyloidosis and Fabry Disease in a Hemodialysis Patient.
Taguchi K; Moriyama A; Kodama G; Nakayama Y; Fukami K
Intern Med; 2017; 56(7):841-846. PubMed ID: 28381753
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis.
Wang CC; Chen YC; Shiang JC; Lin SH; Chu P; Wu CC
Am J Emerg Med; 2009 Nov; 27(9):1174.e1-3. PubMed ID: 19931789
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia, renal failure, and relapse in multiple myeloma.
Crawford SM
Cancer; 1985 Feb; 55(4):898-900. PubMed ID: 3967182
[TBL] [Abstract][Full Text] [Related]
31. Rapid progression of vascular and soft tissue calcification while being managed for severe and persistent hypocalcemia induced by denosumab treatment in a patient with multiple myeloma and chronic kidney disease.
Ueki K; Yamada S; Tsuchimoto A; Tokumoto M; Kumano T; Kitazono T; Tsuruya K
Intern Med; 2015; 54(20):2637-42. PubMed ID: 26466702
[TBL] [Abstract][Full Text] [Related]
32. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
33. [Amyloidosis of the tongue as a possible diagnostic manifestation of plasmacytoma].
Hoefert S; Schilling E; Philippou S; Eufinger H
Mund Kiefer Gesichtschir; 1999 Jan; 3(1):46-9. PubMed ID: 10077969
[TBL] [Abstract][Full Text] [Related]
34. [Hypercalcemia in a female patient with chronic kidney failure secondary to sarcoidosis: a metabolic study of the calcium metabolism and bone histology].
Caravaca F; Cubero JJ; de Francisco AL; Arrobas M; Pizarro JL; Sánchez-Casado E
Med Clin (Barc); 1991 May; 96(17):659-61. PubMed ID: 2056801
[TBL] [Abstract][Full Text] [Related]
35. [Patient with chronic kidney disease and primary or tertiary hyperparathyroidism--case report].
Błazejewska A; Flisiński M; Pypkowski J; Manitius J
Pol Merkur Lekarski; 2009 Dec; 27(162):484-7. PubMed ID: 20120713
[TBL] [Abstract][Full Text] [Related]
36. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
[TBL] [Abstract][Full Text] [Related]
37. Multiple myeloma: Diagnosis and management issues in patients with pre-existing chronic kidney disease.
Vadlamudi S; Annapareddy SN
Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):9-14. PubMed ID: 26787560
[TBL] [Abstract][Full Text] [Related]
38. Frequency of hypercalcemia in patients of multiple myeloma in Karachi.
Mansoor S; Siddiqui I; Adil S; Kakapeto GN; Fatmi Z
J Coll Physicians Surg Pak; 2005 Jul; 15(7):409-12. PubMed ID: 16197869
[TBL] [Abstract][Full Text] [Related]
39. Role of dialysis in the treatment of severe hypercalcemia: report of two cases successfully treated with hemodialysis and review of the literature.
Cardella CJ; Birkin BL; Rapoport A
Clin Nephrol; 1979 Dec; 12(6):285-90. PubMed ID: 160852
[TBL] [Abstract][Full Text] [Related]
40. [Primary amyloidosis associated with multiple myeloma and renal failure: case report].
Peña O C; Intriago B M; Gray H AM; Cabrera C ME
Rev Med Chil; 2011 Nov; 139(11):1471-4. PubMed ID: 22446653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
